期刊文献+

HDP患者血清circACTR2、miR-525-5p水平与不良妊娠结局的相关性

Correlation between the serum circACTR2 and miR-525-5p levels of women with hypertensive disorder of pregnancy and their adverse pregnancy outcomes
下载PDF
导出
摘要 目的:探讨妊娠期高血压疾病(HDP)患者血清circACTR2、miR-525-5p水平与不良妊娠结局的相关性。方法:选取2020年1月-2022年6月在本院建档并定期产前检查的HDP患者148例为HDP组,产前检查正常并分娩的100例孕妇作为对照组,收集临床资料,根据是否发生不良妊娠结局将HDP患者分为正常妊娠结局组98例、不良妊娠结局组50例。采用实时荧光定量PCR法检测孕妇血清circACTR2和miR-525-5p表达水平;分析HDP患者妊娠结局与临床病理特征关系;采用Spearman法分析HDP患者血清circACTR2和miR-525-5p表达与不良妊娠结局的相关性;采用logisitic回归分析HDP患者不良妊娠结局的影响因素;采用受试者工作特征(ROC)曲线分析HDP患者血清circACTR2、miR-525-5p表达预测不良妊娠结局价值。结果:HDP组血清circACTR2(1.33±0.35)高于对照组(1.08±0.27),miR-525-5p(0.76±0.21)低于对照组(1.02±0.30)(P<0.05);HDP不良妊娠结局患者血清胱抑素C(CysC)、D-二聚体(D-D)、C反应蛋白(CRP)和circACTR2水平高于HDP正常妊娠结局患者,miR-525-5p水平低于HDP正常妊娠结局患者(P<0.05);血清circACTR2水平与不良妊娠结局呈正相关,血清miR-525-5p水平与不良妊娠结局呈负相关(均P<0.05);CysC、D-D、CRP、circACTR2和miR-525-5p异常均为HDP患者不良妊娠结局的影响因素(P<0.05);circACTR2联合miR-525-5p预测HDP患者不良妊娠结局的曲线下面积为0.877,敏感度76.0%,特异度86.7%。结论:HDP患者血清circACTR2表达上调,miR-525-5p表达下调,二者与HDP不良妊娠结局密切相关,二者联合检测对预测HDP患者不良妊娠结局有较好效能。 Objective:To investigate the correlation between the serum circACTR2 and miR-525-5p levels of pregnant women with hypertensive disorder of pregnancy(HDP)and their adverse pregnancy outcomes.Methods:From January 2020 to June 2022,148 pregnant women with HDP who were filed in hospital and underwent regular prenatal examination were selected in study group,and 100 healthy pregnant women who underwent regular prenatal examination and gave birth in hospital during the same period were selected in control group.The clinical data of the women in the two groups were collected.The women in the two groups were divided into group A(98 women with the normal pregnancy outcomes)and group B(50 women with the adverse pregnancy outcomes)according to whether the adverse pregnancy outcome occurred or not.The expression levels of serum circACTR2 and miR-525-5p of the women in the two groups were detected by real-time fluorescent quantitative PCR.The correlation between the pregnancy outcomes of the women with HDP and their clinicopathological features was analyzed.Spearman method was used to analyze the correlation between the expressions of serum circACTR2and miR-525-5p of the women with HDP and their adverse pregnancy outcomes.Logisitic regression was used to analyze the influencing factors of the adverse pregnancy outcomes of the women with HDP.Receiver operating characteristic(ROC)curve was used to analyze the value of the serum circACTR2and miR-525-5p expressions of the women for predicting their adverse pregnancy outcomes.Results:The serum circACTR2level(1.33±0.35)of the women in the study group was significantly higher than that(1.08±0.27)of the women in the control group,and the miR-525-5p level(0.76±0.21)of the women in the study group was significantly lower than that(1.02±0.30)of the women in the control group(P<0.05).The levels of serum cystatin C(CysC),D-dimer(D-D),C-reactive protein(CRP)and circACTR2of the women in group B were significantly higher than those of the women in group A,and the level of miR-525-5p of t
作者 张昌清 梅茹 ZHANG Changqing;MEI Ru(Shiyan Maternal and Child Health Care Hospital,Shiyan,Hubei Province,442000)
出处 《中国计划生育学杂志》 2024年第3期660-664,668,共6页 Chinese Journal of Family Planning
基金 湖北省卫生健康委科研项目(WJ2023F091)。
关键词 妊娠期高血压疾病 circACTR2 miR-525-5p 不良妊娠结局 相关性 预测 Hypertensive disorder of pregnancy CircACTR2 MiR-525-5p Adverse pregnancy outcomes Correlation Prediction
  • 相关文献

参考文献7

二级参考文献77

  • 1白幼鹏.硫酸镁、硝苯地平联合酚妥拉明治疗妊娠期高血压的疗效观察[J].现代诊断与治疗,2020(5):675-677. 被引量:8
  • 2商晶,马晓艳,王虹.妊娠期高血压疾病患者血浆中纤维连接蛋白、肌酐、尿素氮及尿蛋白测定分析[J].中国妇幼保健,2006,21(23):3225-3226. 被引量:9
  • 3American College of Obstetricians and Gynecologists; Task Force Hypertension in Pregnancy. Hypertension in pregnancy. (on) Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [ J]. Obstet Gynecol, 2013, 122(5) :1122-1131. 被引量:1
  • 4Magee LA, Pels A, Helewa M, et al. Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary [ J]. J Obstet Gynaecol Can, 2014, 36 (5) : 416-441. 被引量:1
  • 5Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207. 被引量:1
  • 6Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014 [ J ]. Aust N Z J Obstet Gynaecol, 2015, 55 (1) :11-16. 被引量:1
  • 7Campos-Outcalt D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention [ J ]. J Fam Pract, 2005, 54(6) :517-519. 被引量:1
  • 8Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy[ J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl) : S1- 48. 被引量:1
  • 9Cote AM, Brown MA, Lain E, ct ai. Diagnostic accuracy of urinary spot protein : creatinine ratio for proteinuria in hypertensive pregnant women: systematic review [ J ]. BMJ, 2008, 336 (7651) :1003-1006. 被引量:1
  • 10Churchill D, Beevers GD, Meher S, et al. Diuretics for preventing pre-eclampsia[ J]. Cochrane Database Syst Rev,2007, 24( 1 ) : CD004451. 被引量:1

共引文献298

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部